2 reports

THE COMPANY' S PRODUCT PORTFOLIO INCLUDES WEARABLE INJECTORS, PREFILLED SYRINGES, INSULIN DELIVERY SYSTEMS, DISPOSABLE AND REUSABLE AUTOINJECTORS, DRUG RECONSTITUTION DELIVERY SYSTEMS, OCULAR DELIVERY SYSTEMS AND NOVEL DEVICES FOR TARGETED ORGAN

  • Clinical Trial
  • Injectable Delivery
  • Prosthesis
  • Therapy
  • Merck & Co., Inc.

The company' s research and development department designs several fiber-based solutions which include antifibrillation devices, cardiovascular stents, nicotine-induced angiogenesis, ocular drug delivery for diabetic retinopathy and viral delivery to human tum

  • Gastroenterology
  • Prosthesis
  • United States
  • Company
  • TissueGen, Inc.